Cutler Group LP Scynexis Inc Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 26, 2021	SELL	$5.3 - $7.89 $3,180 - $4,734	-600 Reduced 1.64%	36,000 $6,000
Q2 2021 Jul 19, 2021	BUY	$6.5 - $9.97 $152,100 - $233,298	23,400 Added 177.27%	36,600 $60,000
Q1 2021 Apr 26, 2021	SELL	$6.93 - $9.63 $4,158 - $5,778	-600 Reduced 4.35%	13,200 $15,000
Q4 2020 Jan 21, 2021	BUY	$4.28 - $7.87 $59,064 - $108,606	13,800 New	13,800 $19,000

13.7M

21.9K

2.6K

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $33M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.